Takeda Pharmaceutical (TAK) Net Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -2,157.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -3,647.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 166.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 376.00 |
| 10 | Takeda Pharmaceutical | 2.67 Bn | -3.12 Bn | 5.10 Bn | -195.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -195.00 |
| Mar 31, 2026 | -10.00 |
| Dec 31, 2025 | -2,387.00 |
| Sep 30, 2025 | 14.00 |
| Jun 30, 2025 | 334.00 |
| Mar 31, 2025 | 240.00 |
| Dec 31, 2024 | -1,276.00 |
| Sep 30, 2024 | -292.00 |
| Jun 30, 2024 | -56.00 |
| Mar 31, 2024 | -204.00 |
| Dec 31, 2023 | -790.00 |
| Sep 30, 2023 | 274.00 |
| Jun 30, 2023 | -235.00 |
| Mar 31, 2023 | 1,109.00 |
| Dec 31, 2022 | -366.00 |
| Sep 30, 2022 | 72.00 |
| Jun 30, 2022 | -370.00 |
| Mar 31, 2022 | -2,676.00 |
| Dec 31, 2021 | 1,303.00 |
| Sep 30, 2021 | 493.00 |